3rd generation glp 1 agonist Schematic illustration of monoagonists, dual agonists and triple After I Tired Retatrutide, I'm

The Foundation: Diet, Exercise, and Lifestyle Programs Before any medical intervention, lifestyle modification remains the cornerstone of health and weight management

Stay persistent

Healthcare Systems and Providers: As referenced above, health systems will need to understand how a reduction in certain diseases and a healthier population will impact the demand for different services, and how they need to adapt their service configuration to meet evolving population needs

MORE VIDEOS IN Obesity What is a GLP-1

Therapeutic inhibition of miR-802 protects against obesity through AMPK-mediated regulation of hepatic lipid metabolism

Beyond T2D and obesity, semaglutide was also applied for other indications such as cardiovascular disease, fatty liver, chronic kidney disease, all of which have progressed to Phase 3, expanding the influence of GLP-1RAs into more medical fields